Deal Watch: Ionis Turns To Affiliate Akcea In Amyloidosis
Executive Summary
Biohaven restructures its migraine partnership with Bristol to reduce its downstream royalty commitments. Meanwhile, the pharma partners with GRYT Health's cancer app for patient/caregiver insights into cancer therapy.